What is the target price for flora growth stock?
Mar 31, 2022 · Their forecasts range from $10.00 to $11.50. On average, they expect Flora Growth's share price to reach $10.75 in the next twelve months. This suggests a possible upside of 525.0% from the stock's current price. View analysts' price targets for Flora Growth or view top-rated stocks among Wall Street analysts.
Did flora growth (FLGC) go public?
Nov 22, 2021 · Flora Growth Corp (NASDAQ:FLGC) fell 41% on Friday after the company announced the pricing of its $30 million public stock and warrants offering. Shares were do Flora Growth Corp (NASDAQ:FLGC) Stock Reacts Sharply Negatively After New Stock Offerings - …
How much money does flora growth make per year?
Find the latest Flora Growth Corp. (FLGC) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
Will flora growth (FLGC) outperform or underperform the S&P 500 over the long term?
Sep 15, 2021 · What happened. Flora Growth ( FLGC -2.31% ), which closed at $6 a share on Tuesday, opened at $6.04 on Wednesday and rose 17% to $7.08 in early trading, though it dropped back down to near where ...
Is Flora growth a good stock to buy?
Flora Growth has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Is FLGC a good stock to buy?
Is FLORA GROWTH Stock a good buy in 2022, according to Wall Street analysts? The consensus among 2 Wall Street analysts covering (NASDAQ: FLGC) stock is to Strong Buy FLGC stock.
Will flora growth go up?
Flora Growth Corp (NASDAQ:FLGC) The 2 analysts offering 12-month price forecasts for Flora Growth Corp have a median target of 9.25, with a high estimate of 11.50 and a low estimate of 7.00. The median estimate represents a +450.60% increase from the last price of 1.68.
Is Flora growth a real company?
Flora Growth Corp. operates as a cannabis company. The Company produces organic cannabis oils, cannabidiol infused food and beverage, pharmaceutical grade, medical, and cosmetic-grade derivatives from the cannabis plant.
Where can I buy FLGC stock?
Flora Growth Corp (FLGC) is a common stock listed on the NASDAQ exchange, which means you can buy the stock from most brokers....Follow the steps below to learn how to purchase shares of the stock.Find a reliable broker. ... Fund your new account. ... Search for FLGC on the brokerage app or site. ... Buy the stock.
Is Sundial growers a buy?
During the day the stock fluctuated 5.94% from a day low at $0.52 to a day high of $0.55....Predicted Opening Price for Sundial Growers Inc. of Tuesday, April 19, 2022.Fair opening price April 19, 2022Current price$0.54$0.54 (Undervalued)
Where is Flora growth based?
Toronto, Ontario, CanadaWhere is Flora Growth 's headquarters? Flora Growth is located in Toronto, Ontario, Canada .
Is Flora Growth a buy right now?
2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Flora Growth in the last twelve months. There are currently 2 buy...
Are investors shorting Flora Growth?
Flora Growth saw a increase in short interest in the month of February. As of February 15th, there was short interest totaling 1,600,000 shares, an...
What price target have analysts set for FLGC?
2 equities research analysts have issued 1-year price targets for Flora Growth's shares. Their forecasts range from $10.00 to $11.50. On average, t...
Who are Flora Growth's key executives?
Flora Growth's management team includes the following people: Dr. Bernard Raymond Wilson F.C.A. , FCPA, FCA, ICD.D, LLD(H), Exec. Chairman (Age...
Who are some of Flora Growth's key competitors?
Some companies that are related to Flora Growth include KalVista Pharmaceuticals (KALV) , Mersana Therapeutics (MRSN) , Khosla Ventures Acquisit...
When did Flora Growth IPO?
(FLGC) raised $15 million in an initial public offering on Tuesday, May 11th 2021. The company issued 3,300,000 shares at $4.00-$5.00 per share. Bo...
What is Flora Growth's stock symbol?
Flora Growth trades on the NASDAQ under the ticker symbol "FLGC."
Who are Flora Growth's major shareholders?
Flora Growth's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Mirae Asset Global Investm...
Which institutional investors are buying Flora Growth stock?
FLGC stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Wedbush Securities Inc.,...
Which major investors are buying Flora Growth stock?
FLGC stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Wedbush Securities Inc., Citadel Advisors LLC, Financial Consulate Inc., Virtu Financial LLC, and Mirae Asset Global Investments Co. Ltd..
How do I buy shares of Flora Growth?
Shares of FLGC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
What is Flora Growth's stock price today?
One share of FLGC stock can currently be purchased for approximately $1.85.
How much money does Flora Growth make?
Flora Growth has a market capitalization of $97.71 million and generates $110 thousand in revenue each year.
What happened
Flora Growth ( NASDAQ:FLGC), which closed at $6 a share on Tuesday, opened at $6.04 on Wednesday and rose 17% to $7.08 in early trading, though it dropped back down to near where it started the day in the midafternoon. The stock has had a bumpy ride, with a 52-week high of $21.45 and a low of $2.85.
So what
Investors saw a good bargain. Flora Growth was at the lowest point it had been in months when it hit $5.81 at one point on Tuesday. That was considered too low for a company with Flora Growth's potential, though short-sellers have bought up more than 753,000 shares.
Now what
The cannabis stock was already dropping before it announced its first-half financial numbers on Aug. 15 and perhaps investors weren't impressed. The company said it generated first-half revenue of $2 million, compared to just $100,000 in the same period last year. It also said its gross profit margin was 60% and it had $19 million in cash.
Stock Price Forecast
The 2 analysts offering 12-month price forecasts for Flora Growth Corp have a median target of 9.25, with a high estimate of 11.50 and a low estimate of 7.00. The median estimate represents a +411.05% increase from the last price of 1.81.
Analyst Recommendations
The current consensus among 2 polled investment analysts is to Buy stock in Flora Growth Corp. This rating has held steady since October, when it was unchanged from a Buy rating. Move your mouse over past months for detail
Recent Legislation and Market Conditions Present an Opportunity
Just weeks ago, the U.S. GOP introduced legislation that, if put in place, would deschedule cannabis.
Flora Growth Corp at a Glance
Flora is a global cannabis company that recently IPOed and is growing at an impressive rate, both geographically and financially. The company has a cultivation operation in Columbia, arguably the best place in the world to grow cannabis outdoors, as well as international distribution channels, a variety of brands, and ongoing medical research.
Significant Cost Advantages
The most easily understood and notable inherent advantage Flora has over other cannabis companies is its cost of bulk cannabis, specifically dry flower. With many brands competing for store shelf space, it's important to be able to compete on pricing and still make a profit; otherwise, there is no sustainable way to grow.
Relative Valuation
When factoring in Flora’s recent financial guidance, the shares appear inexpensive and undervalued compared to its peers, without considering its low-cost production. In the chart below, one can see that Flora’s valuation as a multiple of enterprise value or sales (which is relatively consistent among the competing companies, is much less.
Why Is There a Valuation Disconnect?
I think that the company hasn’t yet posted its explosion of revenues and its value is obscured compared to companies already producing more revenues. Flora did, however, guide for $35-45 million in revenue for 2022.
Perspectives on the Valuation Disconnect
What these comparisons didn’t take into account are margins on sales.
Medical Research
Flora’s initial fibromyalgia/pain clinical trial will enroll 90 patients globally, and will gather empirical evidence of molecules to try to help tie their levels to therapeutic effects. This is exciting for the industry since minor cannabinoids such as CBN, CBG, etc. are under-researched compared with THC and CBD.
